03/11/2026
What Is a CRT-D Device?
A CRT-D (Cardiac Resynchronization Therapy Defibrillator) is an implantable cardiac device that combines two distinct therapeutic functions into a single unit: cardiac resynchronization therapy (biventricular pacing) and an implantable cardioverter-defibrillator (ICD). It is used in patients with advanced heart failure who are also at high risk of sudden cardiac death from dangerous ventricular arrhythmias.
The Problem It Addresses
In many patients with heart failure, the two lower chambers of the heart (the ventricles) do not beat in a coordinated, synchronized manner. This condition is called electromechanical dyssynchrony, and it is most commonly caused by a conduction abnormality known as left bundle branch block (LBBB). When the ventricles contract out of sync, the heart pumps blood less efficiently, which worsens heart failure symptoms and accelerates cardiac deterioration. Additionally, a weakened heart muscle is prone to life-threatening arrhythmias such as ventricular fibrillation or ventricular tachycardia, which can cause sudden cardiac death.
How a CRT-D Works
A CRT-D device consists of a small pulse generator (implanted under the skin below the collarbone) connected to
three leads (wires) threaded through the veins into the heart:
Lead
Placement
Function
Right atrial lead
Right atrium (upper chamber)
Senses the heart's natural rhythm
Right ventricular lead
Right ventricle (lower chamber)
Paces the right ventricle; also delivers defibrillation shocks
Left ventricular lead
Left ventricle (via coronary sinus)
Paces the left ventricle simultaneously
By delivering precisely timed electrical impulses to both ventricles simultaneously, the device restores coordinated contraction, improves the heart's pumping efficiency, and increases the volume of blood ejected with each beat. The built-in ICD component continuously monitors the heart rhythm and, if it detects a life-threatening arrhythmia, delivers an electric shock to restore a normal rhythm.
CRT-D vs. CRT-P: What Is the Difference?
There are two main types of cardiac resynchronization devices:
Feature
CRT-P (Pacemaker only)
CRT-D (Pacemaker + Defibrillator)
A CRT-D is recommended when a patient needs resynchronization and is at elevated risk of sudden cardiac death — for example, those with a very low left ventricular ejection fraction (LVEF ≤ 35%).
Who Needs a CRT-D?
Clinical guidelines (e.g., from the American Heart Association and ACC) recommend CRT-D for patients who meet all of the following criteria:
Left ventricular ejection fraction (LVEF) of less than 35–36% despite optimal medical therapy
Symptomatic heart failure (NYHA Class II, III, or ambulatory Class IV)
Wide QRS complex on ECG (typically ≥ 120–150 ms), indicating dyssynchrony
Left bundle branch block (LBBB) morphology (strongest indication)
Sinus rhythm (though some patients with atrial fibrillation may also qualify)
Benefits
CRT-D therapy has been shown in multiple large clinical trials to:
Improve the heart's pumping function and reduce symptoms such as shortness of breath and fatigue
Increase exercise tolerance and quality of life
Reduce hospitalizations for heart failure
Decrease or reverse cardiac remodeling (the enlargement and weakening of the heart muscle)
Reduce mitral valve regurgitation
Prolong survival by addressing both pump failure and sudden cardiac death
Risks and Complications
As with any implantable device, CRT-D carries procedural and long-term risks, including:
Infection at the implant site (incidence up to ~3.3%)
Lead dislodgement (2.9–10% in clinical trials)
Pocket hematoma (bleeding around the device, up to ~2.5%)
Pneumothorax (collapsed lung, rare, ~0.66%)
Phrenic nerve stimulation (causing diaphragm twitching, up to 13%)
Coronary sinus perforation or dissection (rare, ~0.28%)
Inappropriate shocks from the ICD component
The Implantation Procedure
The procedure is performed in a cardiac catheterization laboratory under sedation and local anesthesia. It typically takes several hours.
The surgeon threads the three leads through the subclavian or cephalic vein into the heart, positions them under fluoroscopic (X-ray) guidance, connects them to the pulse generator, and implants the generator in a small pocket created beneath the skin below the collarbone. Most patients are discharged within one to two days and can return to normal activities within a week.
Key Takeaway
A CRT-D is a sophisticated, life-saving device for patients with advanced heart failure and dyssynchrony who are also at risk of sudden cardiac death. It simultaneously corrects the heart's inefficient pumping pattern through biventricular pacing. It stands ready to terminate dangerous arrhythmias with a defibrillation shock — effectively addressing two of the leading causes of death in heart failure patients with a single implanted device.
Sources: Cleveland Clinic | NIH/NCBI StatPearls | American Heart Association
